Answers are grounded in this paper and cite their sources.
This study aims to analyze patents relating to new plant varieties of Lamiaceae, a plant family recognized for the interest of these genera in the medicinal and aromatic fields. The study also seeks to identify the genera and species most exploited in innovative applications. To identify the latest trends in this area, we systematically reviewed patents concentrating on new varieties of Lamiaceae. The relevant patent documents were identified within a specialized database using the International Patent Classification. The United States encompasses all plant patents in this area, and it is considered the leading jurisdiction. This is also confirmed by the American organizations, which led the way with the most applicants. The Lamiaceae genera concerned with the legal protection of new plant varieties comprise 23 genera. Among them are Plectranthus, Salvia, and Lavandula, which present 55.4% of total patent documents in this area. The essential objective claimed by the majority of patent documents analyzed in this study is ornamental. Furthermore, other inventive purposes are also claimed in the patent documents, but with a low percentage, such as genetic engineering, the selection of a compound, etc.
No takes yet. Share an insight, caveat, or question.
Boukhari et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: